The present invention relates to body fluid testing devices and more specifically, but not exclusively, concerns a body fluid testing device that incorporates a test media cassette which contains test media used to test body fluid.
General Fluid Testing
The acquisition and testing of body fluids is useful for many purposes, and continues to grow in importance for use in medical diagnosis and treatment, and in other diverse applications. In the medical field, it is desirable for lay operators to perform tests routinely, quickly and reproducibly outside of a laboratory setting, with rapid results and a readout of the resulting test information. Testing can be performed on various body fluids, and for certain applications is particularly related to the testing of blood and/or interstitial fluid. Such fluids can be tested for a variety of characteristics of the fluid, or analytes contained in the fluid, in order to identify a medical condition, determine therapeutic responses, assess the progress of treatment, and the like.
General Test Steps
The testing of body fluids basically involves the steps of obtaining the fluid sample, transferring the sample to a test device, conducting a test on the fluid sample, and displaying the results. These steps are generally performed by a plurality of separate instruments or devices.
Acquiring—Vascular
One method of acquiring the fluid sample involves inserting a hollow needle or syringe into a vein or artery in order to withdraw a blood sample. However, such direct vascular blood sampling can have several limitations, including pain, infection, and hematoma and other bleeding complications. In addition, direct vascular blood sampling is not suitable for repeating on a routine basis, can be extremely difficult and is not advised for patients to perform on themselves.
Acquiring—Incising
The other common technique for collecting a body fluid sample is to form an incision in the skin to bring the fluid to the skin surface. A lancet, knife or other cutting instrument is used to form the incision in the skin. The resulting blood or interstitial fluid specimen is then collected in a small tube or other container, or is placed directly in contact with a test strip. The fingertip is frequently used as the fluid source because it is highly vascularized and therefore produces a good quantity of blood. However, the fingertip also has a large concentration of nerve endings, and lancing the fingertip can therefore be painful. Alternate sampling sites, such as the palm of the hand, forearm, earlobe and the like, may be useful for sampling, and are less painful. However, they also produce lesser amounts of blood. These alternate sites therefore are generally appropriate for use only for test systems requiring relatively small amounts of fluid, or if steps are taken to facilitate the expression of the body fluid from the incision site.
Various methods and systems for incising the skin are known in the art. Exemplary lancing devices are shown, for example, in U.S. Pat. No. Re 35,803, issued to Lange, et al. on May 19, 1998; U.S. Pat. No. 4,924,879, issued to O'Brien on May 15, 1990; U.S. Pat. No. 5,879,311, issued to Duchon et al. on Feb. 16, 1999; U.S. Pat. No. 5,857,983, issued to Douglas on Jan. 12, 1999; U.S. Pat. No. 6,183,489, issued to Douglas et al. on Feb. 6, 2001; U.S. Pat. No. 6,332,871, issued to Douglas et al. on Dec. 25, 2001; and U.S. Pat. No. 5,964,718, issued to Duchon et al. on Oct. 12, 1999. A representative commercial lancing device is the Accu-Chek Softclix lancet.
Expressing
Patients are frequently advised to urge fluid to the incision site, such as by applying pressure to the area surrounding the incision to milk or pump the fluid from the incision. Mechanical devices are also known to facilitate the expression of body fluid from an incision. Such devices are shown, for example, in U.S. Pat. No. 5,879,311, issued to Duchon et al. on Feb. 16, 1999; U.S. Pat. No. 5,857,983, issued to Douglas on Jan. 12, 1999; U.S. Pat. No. 6,183,489, issued to Douglas et al. on Feb. 6, 2001; U.S. Pat. No. 5,951,492, issued to Douglas et al. on Sep. 14, 1999; U.S. Pat. No. 5,951,493, issued to Douglas et al. on Sep. 14, 1999; U.S. Pat. No. 5,964,718, issued to Duchon et al. on Oct. 12, 1999; and U.S. Pat. No. 6,086,545, issued to Roe et al. on Jul. 11, 2000. A representative commercial product that promotes the expression of body fluid from an incision is the Amira AtLast blood glucose system.
Sampling
The acquisition of the produced body fluid, hereafter referred to as the “sampling” of the fluid, can take various forms. Once the fluid specimen comes to the skin surface at the incision, a sampling device is placed into contact with the fluid. Such devices may include, for example, systems in which a tube or test strip is either located adjacent the incision site prior to forming the incision, or is moved to the incision site shortly after the incision has been formed. A sampling tube may acquire the fluid by suction or by capillary action. Such sampling systems may include, for example, the systems shown in U.S. Pat. No. 6,048,352, issued to Douglas et al. on Apr. 11, 2000; U.S. Pat. No. 6,099,484, issued to Douglas et al. on Aug. 8, 2000; and U.S. Pat. No. 6,332,871, issued to Douglas et al. on Dec. 25, 2001. Examples of commercial sampling devices include the Roche Compact, Amira AtLast, Glucometer Elite and Therasense FreeStyle test strips.
Testing General
The body fluid sample may be analyzed for a variety of properties or components, as is well known in the art. For example, such analysis may be directed to hematocrit, blood glucose, coagulation, lead, iron, etc. Testing systems include such means as optical (e.g., reflectance, absorption, fluorescence, Raman, etc.), electrochemical, and magnetic means for analyzing the sampled fluid. Examples of such test systems include those in U.S. Pat. No. 5,824,491, issued to Priest et al. on Oct. 20, 1998; U.S. Pat. No. 5,962,215, issued to Douglas et al. on Oct. 5, 1999; and U.S. Pat. No. 5,776,719, issued to Douglas et al. on Jul. 7, 1998.
Typically, a test system takes advantage of a reaction between the body fluid to be tested and a reagent present in the test system. For example, an optical test strip will generally rely upon a color change, i.e., a change in the wavelength absorbed or reflected by dye formed by the reagent system used. See, e.g., U.S. Pat. Nos. 3,802,842; 4,061,468; and 4,490,465.
Blood Glucose
A common medical test is the measurement of blood glucose level. The glucose level can be determined directly by analysis of the blood, or indirectly by analysis of other fluids such as interstitial fluid. Diabetics are generally instructed to measure their blood glucose level several times a day, depending on the nature and severity of their diabetes. Based upon the observed pattern in the measured glucose levels, the patient and physician determine the appropriate level of insulin to be administered, also taking into account such issues as diet, exercise and other factors.
In testing for the presence of an analyte such as glucose in a body fluid, test systems are commonly used which take advantage of an oxidation/reduction reaction which occurs using an oxidase/peroxidase detection chemistry. The test reagent is exposed to a sample of the body fluid for a suitable period of time, and there is a color change if the analyte (glucose) is present. Typically, the intensity of this change is proportional to the concentration of analyte in the sample. The color of the reagent is then compared to a known standard which enables one to determine the amount of analyte present in the sample. This determination can be made, for example, by a visual check or by an instrument, such as a reflectance spectrophotometer at a selected wavelength, or a blood glucose meter. Electrochemical and other systems are also well known for testing body fluids for properties on constituents.
Testing Media
As mentioned above, diabetics typically have to monitor their blood glucose levels throughout the day so as to ensure that their blood glucose remains within an acceptable range. Some types sampling devices require the use of testing strips that contain media for absorbing and/or testing the body fluid, such as blood. After testing, the testing media contaminated with blood can be considered a biohazard and needs to be readily disposed in order to avoid other individuals from being exposed to the contaminated test strip. This can be especially inconvenient when the person is away from home, such as at restaurant. Moreover, individual test elements can become easily mixed with other test strips having different expiration dates. The use of expired test elements may create false readings, which can result in improper treatment of the patient, such as improper insulin dosages for diabetics.
Test Media Cassettes
Analytical systems with test media cassettes which allow multiple testing have been previously described (see e.g. U.S. Pat. No. 4,218,421 and U.S. Pat. No. 5,077,010) for the environment of automated laboratory systems which use pipettes to apply sample fluid to the test media. These systems are therefore not suited to be used by lay people as e.g. diabetics for self testing. DE 198 19 407 describes a test element cassette for use in the home environment.
It was an aim of the present invention to facilitate user handling for body fluid testing.
The present invention provides various devices and methods for testing body fluid. The present invention encompasses a body fluid testing device that contains a plurality of test media.
In accordance with one aspect of the present invention, there is provided a body fluid testing device for analyzing a body fluid. The testing device includes a test media cassette that includes a test media tape adapted to collect the body fluid. The cassette includes a supply portion that stores an uncontaminated section of the test media tape. A storage portion for storing a contaminated section of the test media tape is further employed.
The testing device is a handheld device that can be conveniently handled by an user. The test media tape may be a part of the testing device so that the whole device is discarded when the test media tape is used up or the test media tape may be arranged in a disposable cassette which is received in the testing device. An important aspect of a first embodiment of the present invention is that a portion of the test media tape onto which body fluid will be applied is exposed in a tip like shape. For this purpose the test media tape is guided over a convex tip portion which may belong to the testing device or to the test media cassette. Due to this tip portion body fluid can be applied to the exposed portion of the test media tape very conveniently.
A sensing region is positioned between the supply portion and the storage portion to sense at least one property or analyte of the body fluid collected on the test media tape at the exposure portion of the cassette.
The testing device further may comprise a pricking unit for pricking a body portion. The lancing opening of that pricking unit advantageously can be arranged in or close to the convex portion so that the tip portion can be used for convenient pricking as well. The pricking unit may be arranged below the test media tape and a lancing device can either penetrate the test media tape or can extend through a recess in the test media tape.
A further aspect of the present invention is a method and a device for visual user guidance for application of body fluid samples. According to this embodiment the testing device comprises an illumination unit which indicates by illumination of a portion of a test element where body fluid is to be applied. The illumination serves for a timely and/or spatially guidance of the user to apply body fluid. Further the illumination may serve to indicate the location where to position a body portion for pricking. An illuminated area on the test medium may further indicate the amount (or the droplet size) of body fluid which is required by the testing device.
Another aspect of the present invention concerns a test cassette for collecting a body fluid sample. The cassette includes a test media tape, which has a section for receiving test media tape that is contaminated with past samples of the body fluid and a section for storing and providing uncontaminated test media tape. The cassette includes a housing that has a supply portion in which the uncontaminated section of the test media tape is enclosed. The housing further includes a storage portion in which the contaminated section of the test media tape is enclosed after contamination. The cassette further includes a convex tip portion over which the test media tape runs and at which the test media tape is exposed to the body fluid. A supply reel is disposed in the supply portion of the housing around which the uncontaminated section of the test media tape is wrapped. A storage reel is disposed in the storage portion of the housing around which the contaminated section of the test media tape is wrapped.
Further this invention concerns a method of using a testing device comprising the steps of
In case of an embodiment employing a test media tape a number of test media are located on the same test element (e.g. a tape). The steps for bringing a test element into a sample application position and removing it from this position in this case are made by shifting the position of the test element. It further has to be understood that step e) can be made prior to step d) if evaluation is performed at a different position than sample application.
In case of a device receiving single use test elements an individual test element is brought into the sample application position and is taken out of the device after use.
A further step may be included in the above method which concerns a pricking for generating a body opening.
Other forms, embodiments, objects, features, advantages, benefits and aspects of the present invention shall become apparent from the detailed drawings and description contained herein.
For the purposes of promoting an understanding of the principles of the invention, reference will now be made to the embodiments illustrated in the drawings and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended, such alterations and further modifications in the illustrated device, and such further applications of the principles of the invention as illustrated therein being contemplated as would normally occur to one skilled in the art to which the invention relates. One embodiment of the invention is shown in great detail, although it will be apparent to those skilled in the art that some of the features which are not relevant to the invention may not be shown for the sake of clarity.
A first general concept of the present invention concerns a body fluid testing device that incorporates a test media tape. The test media tape holds test media that are used to collect body fluid samples which are analyzed with a sensor. Advantageously the test media tape is housed in a cassette so that after the test media of a cassette are used up a fresh test media cassette can be inserted into the testing device. The test media tape is indexed before or after each test so that successive tests can be performed without requiring disposal of individual test media. The test media can be indexed manually or automatically.
The test medium is a medium which contains a test chemistry that with analyte from a sample leads to detectable results. For further details of test chemistry and testing see section “Testing General”. Preferably the test media are designed to soak up the test fluid sample. This prevents the testing device from becoming contaminated by body fluid sample. As will be described in more detail later on it is preferred to employ a test media tape which comprises a transport tape on which test media are arranged with free spaces between successive test media. The preferred arrangement therefore has a structure with regions as follows: tape with test medium-tape without test medium—tape with test medium—and so on. The tape can be made e.g. from conventional plastic tape. The test media are attached to the tape, e.g. by gluing, welding or by use of an adhesive tape.
A body fluid testing device (10) according to the present invention is shown in
The testing device can be approached to a body surface (e.g. finger or arm) on which a body fluid sample is located with the tip portion. In order to make the tip portion easily accessible and visible as the location where sample has to be applied it is preferred to employ a tip like shape. Easy access and good visibility can be achieved by a tip portion that changes the direction of movement of the test media tape by an angle of more than 60 degree, preferably more than 90 degree.
According to a second inventive concept of the present invention body fluid application can be further facilitated by illuminating a portion (30′) of the test tape where the body fluid sample has to be applied. For this functionality a translucent test medium is advantageous. If the test medium, however, is opaque a translucent portion of the test media tape without test medium applied to it may be employed. However, most test media for analyte testing as e.g. reflectometric glucose test media are partially transparent and therefore produce an easily visible lighted area on the frontside of the test medium when illumination from the backside is made and the layer of test medium is not too thick. The artisan in this field knows how to make test media which transmit enough light that an illumination from the backside can easily be seen by a user. It is preferred to illuminate the backside of the test media tape with colored light (e.g. red or green) so that a better visible illumination results as by illumination with white light would result.
The second inventive concept of the present invention includes the user guidance by illuminating a portion of the test medium or a test element to which sample fluid has to be applied. As already described above illumination is made when the device is ready to receive sample fluid. Further the size of the illuminated area on the frontside of the test medium advantageously can be chosen to indicate the size of the test medium which needs to be filled with sample fluid to allow proper analysis. The user therefore can visually control whether he has applied enough sample fluid to the correct position on the test medium. The illumination for user guidance is made when the test element is positioned in the testing device for sample reception. For illumination the same optics as for optical evaluation can be used. However, if it is desired to indicate the size of sample fluid to be applied to the test medium it is preferred to employ a separate light source for this purpose or to employ means that change the size of illuminated area. For indication of application site and indication of desired sample volume in the latter case a first surface of the test medium is illuminated and a differently sized area (located within the first area) is illuminated for evaluating the test medium.
There is a certain connection between the area wetted by sample fluid and the recognition whether proper analysis can be done. Test media require a certain amount of sample volume to allow a reliable measurement. The amount of liquid which is necessary depends on a number of factors as the test chemistry, test architecture (layer structure with e.g. additional layers for removal of cells etc.), optics or electrodes and so on. For an actual testing device where these factors are fixed and the test medium is standardized the minimum amount of sample fluid needed for reliable measurement is a fixed number. On the other side the area on the test medium covered by sample fluid is related to the volume of sample fluid. In case of a non-absorbing test medium a drop is formed with an area that is dependent on surface tension. Based upon known surface conditions the area therefore can be related to the sample volume. In case of an absorbing test medium the absorption capacity per area determines the area which is wetted by a certain amount of fluid. The wetted area on the test medium therefore is closely related to the volume of fluid applied.
The testing device according to this second inventive idea illuminates an area of the test medium which becomes wetted when a sample volume equal or above the volume required for proper analysis is applied. The user therefore can visually control whether the fluid sample he has applied covers the whole illuminated area or not. This allows a twofold control
Further it is advantageous to combine the user guidance by illumination with monitoring of fluid application to the test medium. Such monitoring is possible by optical or electrochemical detection. In an optical method light reflected from the test medium is detected and a change in intensity is monitored to detect sample fluid application. In an electrical process conductivity or capacity can be monitored to detect sample application. The before mentioned changes of measurement signals can be evaluated to give one or more of the following information:
Illumination at the tip portion further may serve to guide the user through the use process of the testing device. Blinking e.g. may indicate that the testing device is ready for sample fluid to be applied and a constant light or a deenergization of the light may show that sample has been successfully applied.
Illumination as described above can be implemented by employing a separate light source which is controlled by a control unit. However, in case of optical measurement as common in this field the light source for measurement can advantageously be employed for illumination of the test medium at the sampling position as well.
A testing device according to the above embodiment further has a control unit for controlling activation of the light source for illumination of the test medium. The control unit activates the light source when the instrument waits for fluid sample to be applied to the test medium. Illumination in this sense does not only mean constant illumination but also includes e.g. blinking. The illumination may remain until the user shuts down the testing device but it is preferred that the control unit deactivates illumination or changes the type of illumination when proper application of fluid to the test medium is detected (as described above). However, in case of optical evaluation of the test medium the illumination may be activated again for measuring an analyte concentration in the fluid sample.
The user guidance by illumination can be employed advantageously in embodiments where the test media portion for application of sample fluid is located at a tip. In this geometric setup the user can see the light when he is applying sample to the test medium. By sake of the tip geometry the user can visually monitor the application process, especially the approaching of the tip portion by a body portion on which body fluid is located. Due to illumination at the tip portion light is not shielded by the approaching body portion until shortly before contacting the illuminated area with sample fluid.
However, the user guidance by illumination of the sample application area can be used in a much wider field as shown in
In
It is preferred to locate the sensing portion of a sensor unit at the exposure portion since measurement can be done right after the sample has been applied and no tape transport is necessary before measurement. However, it is also possible to locate a measurement unit for analyte concentration measurement at another position to which the test medium is moved after sample has been applied to it.
In
The tip portions (20) of
In
In
The rotational axis (95) of the storage reel belongs to the cassette of the depicted embodiment. However, this axis can also be realized by a recess for receiving an axis belonging to the testing device. The supply reel (100) (or a drive which drives that reel) should have a tension control that controls tension of the test media tape and therefore avoids a too loose or too much tensioned test media tape.
As already mentioned the test media tape is exposed to the environment at the tip portion. Most test media are, however, destroyed or altered by humidity, sunlight etc. Therefore measures have to be taken to shelter the test media. A first measure is to package the whole cassette (90) before use such that a contact with humidity from the surrounding is prevented. This can be achieved by e.g. a blister package. Bearing in mind that the cassette housing (91) can be made as a body closed against humidity with the exception of the tip region embodiments can be contemplated which employ a humidity proof cover over the tip region which can be removed prior to use of the cassette.
While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only the preferred embodiment has been shown and described and that all changes, equivalents, and modifications that come within the spirit of the inventions defined by following claims are desired to be protected. All publications, patents, and patent applications cited in this specification are incorporated by reference as if each individual publication, patent, or patent application were specifically and individually indicated to be incorporated by reference and set forth in its entirety herein.
Number | Date | Country | Kind |
---|---|---|---|
02026242 | Nov 2002 | EP | regional |
The present application is a continuation of International Patent Application No. PCT/EP2003/013298, filed Nov. 26, 2003, which claims foreign priority to European Patent Application No. 02 026 242.4, filed Nov. 26, 2002, which are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2714890 | Vang | Aug 1955 | A |
3086288 | Balamuth et al. | Apr 1963 | A |
3208452 | Stern | Sep 1965 | A |
3298789 | Mast | Jan 1967 | A |
3673475 | Britton, Jr. | Jun 1972 | A |
3802842 | Lange et al. | Apr 1974 | A |
3832776 | Sawyer | Sep 1974 | A |
4061468 | Lange et al. | Dec 1977 | A |
4077406 | Sandhage et al. | Mar 1978 | A |
4154228 | Feldstein et al. | May 1979 | A |
4203446 | Hofert et al. | May 1980 | A |
4218421 | Mack, Jr. et al. | Aug 1980 | A |
4223674 | Fluent et al. | Sep 1980 | A |
4230118 | Holman et al. | Oct 1980 | A |
4356826 | Kubota | Nov 1982 | A |
4449529 | Burns et al. | May 1984 | A |
4462405 | Ehrlich | Jul 1984 | A |
4490465 | Limbach et al. | Dec 1984 | A |
4518384 | Tarello et al. | May 1985 | A |
4535773 | Yoon | Aug 1985 | A |
4553541 | Burns | Nov 1985 | A |
4627445 | Garcia et al. | Dec 1986 | A |
4637403 | Garcia et al. | Jan 1987 | A |
4653513 | Dombrowski | Mar 1987 | A |
4750489 | Berkman et al. | Jun 1988 | A |
4787398 | Garcia et al. | Nov 1988 | A |
4794926 | Munsch et al. | Jan 1989 | A |
4823806 | Bajada | Apr 1989 | A |
4924879 | O'Brien | May 1990 | A |
4994068 | Hufnagle | Feb 1991 | A |
4995402 | Smith et al. | Feb 1991 | A |
5029583 | Meserol et al. | Jul 1991 | A |
5035704 | Lambert et al. | Jul 1991 | A |
5047044 | Smith et al. | Sep 1991 | A |
5053199 | Keiser et al. | Oct 1991 | A |
5077010 | Ishizaka et al. | Dec 1991 | A |
5097810 | Fishman et al. | Mar 1992 | A |
5145565 | Kater et al. | Sep 1992 | A |
5152775 | Ruppert | Oct 1992 | A |
5188118 | Terwilliger | Feb 1993 | A |
5189751 | Giuliani et al. | Mar 1993 | A |
5222504 | Solomon | Jun 1993 | A |
5228972 | Osaka et al. | Jul 1993 | A |
5279294 | Anderson et al. | Jan 1994 | A |
5304468 | Phillips et al. | Apr 1994 | A |
5307263 | Brown | Apr 1994 | A |
5320808 | Holen et al. | Jun 1994 | A |
5366470 | Ramel | Nov 1994 | A |
5368047 | Suzuki et al. | Nov 1994 | A |
5415169 | Siczek et al. | May 1995 | A |
5418142 | Kiser et al. | May 1995 | A |
5451350 | Macho et al. | Sep 1995 | A |
5472427 | Rammler | Dec 1995 | A |
5474084 | Cunniff | Dec 1995 | A |
5514152 | Smith | May 1996 | A |
5515170 | Matzinger et al. | May 1996 | A |
5522255 | Neel et al. | Jun 1996 | A |
5529074 | Greenfield | Jun 1996 | A |
5575403 | Charlton et al. | Nov 1996 | A |
5580794 | Allen | Dec 1996 | A |
5630986 | Charlton et al. | May 1997 | A |
5632410 | Moulton et al. | May 1997 | A |
5648047 | Kardish et al. | Jul 1997 | A |
5686829 | Girault | Nov 1997 | A |
5700695 | Yassinzadeh et al. | Dec 1997 | A |
5714390 | Hallowitz et al. | Feb 1998 | A |
5720924 | Eikmeier et al. | Feb 1998 | A |
5738244 | Charlton et al. | Apr 1998 | A |
RE35803 | Lange et al. | May 1998 | E |
5758643 | Wong et al. | Jun 1998 | A |
5776157 | Thorne et al. | Jul 1998 | A |
5776719 | Douglas et al. | Jul 1998 | A |
5788651 | Weilandt | Aug 1998 | A |
5800781 | Gavin et al. | Sep 1998 | A |
5801057 | Smart et al. | Sep 1998 | A |
5810199 | Charlton et al. | Sep 1998 | A |
5823973 | Racchini et al. | Oct 1998 | A |
5824491 | Priest et al. | Oct 1998 | A |
5830219 | Bird et al. | Nov 1998 | A |
5846490 | Yokota et al. | Dec 1998 | A |
5854074 | Charlton et al. | Dec 1998 | A |
5855801 | Lin et al. | Jan 1999 | A |
5857983 | Douglas et al. | Jan 1999 | A |
5863800 | Eikmeier et al. | Jan 1999 | A |
5871494 | Simons et al. | Feb 1999 | A |
5872713 | Douglas et al. | Feb 1999 | A |
5879311 | Duchon et al. | Mar 1999 | A |
5880829 | Kauhaniemi et al. | Mar 1999 | A |
5885211 | Eppstein et al. | Mar 1999 | A |
5891053 | Sesekura | Apr 1999 | A |
5916229 | Evans | Jun 1999 | A |
5935075 | Casscells et al. | Aug 1999 | A |
5938679 | Freeman et al. | Aug 1999 | A |
5951492 | Douglas et al. | Sep 1999 | A |
5951493 | Douglas et al. | Sep 1999 | A |
5951582 | Thorne et al. | Sep 1999 | A |
5962215 | Douglas et al. | Oct 1999 | A |
5964718 | Duchon et al. | Oct 1999 | A |
5968063 | Chu et al. | Oct 1999 | A |
5971941 | Simons et al. | Oct 1999 | A |
5997561 | Bocker et al. | Dec 1999 | A |
6027459 | Shain et al. | Feb 2000 | A |
6036924 | Simons et al. | Mar 2000 | A |
6048352 | Douglas et al. | Apr 2000 | A |
6071294 | Simons et al. | Jun 2000 | A |
6086545 | Roe et al. | Jul 2000 | A |
6093156 | Cunningham et al. | Jul 2000 | A |
6099484 | Douglas et al. | Aug 2000 | A |
6117630 | Reber et al. | Sep 2000 | A |
6120462 | Hibner et al. | Sep 2000 | A |
6132449 | Lum et al. | Oct 2000 | A |
6136013 | Marshall et al. | Oct 2000 | A |
6139562 | Mauze et al. | Oct 2000 | A |
6143164 | Heller et al. | Nov 2000 | A |
6152942 | Brenneman et al. | Nov 2000 | A |
6155992 | Henning et al. | Dec 2000 | A |
6156051 | Schraga | Dec 2000 | A |
6159424 | Kauhaniemi et al. | Dec 2000 | A |
6171325 | Mauze et al. | Jan 2001 | B1 |
6176865 | Mauze et al. | Jan 2001 | B1 |
6183489 | Douglas et al. | Feb 2001 | B1 |
6193673 | Viola et al. | Feb 2001 | B1 |
6203504 | Latterell et al. | Mar 2001 | B1 |
6206841 | Cunningham et al. | Mar 2001 | B1 |
6210420 | Mauze et al. | Apr 2001 | B1 |
6210421 | Bocker et al. | Apr 2001 | B1 |
6228100 | Schraga | May 2001 | B1 |
6231531 | Lum et al. | May 2001 | B1 |
6261241 | Burbank et al. | Jul 2001 | B1 |
6261245 | Kawai et al. | Jul 2001 | B1 |
6283926 | Cunningham et al. | Sep 2001 | B1 |
6285454 | Douglas et al. | Sep 2001 | B1 |
6306104 | Cunningham et al. | Oct 2001 | B1 |
6306152 | Verdonk et al. | Oct 2001 | B1 |
6315738 | Nishikawa et al. | Nov 2001 | B1 |
6319210 | Douglas et al. | Nov 2001 | B1 |
6332871 | Douglas et al. | Dec 2001 | B1 |
6352514 | Douglas et al. | Mar 2002 | B1 |
6364889 | Kheiri et al. | Apr 2002 | B1 |
6364890 | Lum et al. | Apr 2002 | B1 |
6375627 | Mauze et al. | Apr 2002 | B1 |
6379317 | Kintzig et al. | Apr 2002 | B1 |
6379969 | Mauze et al. | Apr 2002 | B1 |
6391005 | Lum et al. | May 2002 | B1 |
6402701 | Kaplan et al. | Jun 2002 | B1 |
6402704 | McMorrow | Jun 2002 | B1 |
6409740 | Kuhr et al. | Jun 2002 | B1 |
6461496 | Feldman et al. | Oct 2002 | B1 |
6472220 | Simons et al. | Oct 2002 | B1 |
6485439 | Roe et al. | Nov 2002 | B1 |
6488891 | Mason et al. | Dec 2002 | B2 |
6491709 | Sharma et al. | Dec 2002 | B2 |
6497845 | Sacherer | Dec 2002 | B1 |
6503210 | Hirao et al. | Jan 2003 | B1 |
6506575 | Knappe et al. | Jan 2003 | B1 |
6530892 | Kelly | Mar 2003 | B1 |
6988996 | Roe et al. | Jan 2006 | B2 |
20010031931 | Cunningham et al. | Oct 2001 | A1 |
20020002344 | Douglas et al. | Jan 2002 | A1 |
20020004196 | Whitson | Jan 2002 | A1 |
20020052618 | Haar et al. | May 2002 | A1 |
20020082543 | Park et al. | Jun 2002 | A1 |
20020103499 | Perez et al. | Aug 2002 | A1 |
20030088191 | Freeman et al. | May 2003 | A1 |
20030233112 | Alden et al. | Dec 2003 | A1 |
20030233113 | Alden et al. | Dec 2003 | A1 |
Number | Date | Country |
---|---|---|
42 34 553 | Apr 1993 | DE |
198 19 407 | Nov 1999 | DE |
198 49 539 | May 2000 | DE |
198 57 426 | Jun 2000 | DE |
101 05 549 | Aug 2002 | DE |
0 351 891 | Jan 1990 | EP |
0 608 820 | Aug 1994 | EP |
0 823 636 | Feb 1998 | EP |
H06-033413 | Aug 1989 | JP |
04194660 | Jul 1992 | JP |
H06-222057 | Aug 1994 | JP |
9-276235 | Oct 1997 | JP |
H10-148635 | Jun 1998 | JP |
2000116768 | Apr 2000 | JP |
WO 9302720 | Feb 1993 | WO |
WO 9312726 | Jul 1993 | WO |
WO 9742888 | Nov 1997 | WO |
WO 0100090 | Jan 2001 | WO |
WO 0108551 | Feb 2001 | WO |
WO 0134029 | May 2001 | WO |
WO 0166010 | Sep 2001 | WO |
WO 02056769 | Jul 2002 | WO |
WO 2004047642 | Jun 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20050201897 A1 | Sep 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/EP03/13298 | Nov 2003 | US |
Child | 11124591 | US |